Reform of pharma legislation: the debate on regulatory data protection by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
Lessons learnt to transition from Horizon 2020 to the new FP10 by Giuliana Miglierini The European Commission published the ex post evaluation of Horizon 2020 (H2020), the FP8 framework…
The risk of a biosimilar void in Europe by Giuliana Miglierini The undergoing revision of the pharmaceutical legislation aims, among others, to redefine data protection to…
The hearings at the ENVI committee on the revision of pharmaceutical legislation by Giuliana Miglierini As a part of the ongoing process of revision of the pharmaceutical legislation, the Committee…
Insights to the Industrial Pharmacist role for the future A concept paper from EIPG Advisory Group on Competencies vol.2, 2023 This paper is an update of the…
The New Pharmaceutical Legislation by Jane Nicholson To celebrate the 70th Anniversary of the foundation of the Belgian Association of Industrial Pharmacists…